$140.6
Currently 34 wall-street analysts regularly analyze the financials of Neurocrine Biosciences Inc. on a frequent basis to provide recommendations along with target share price. 34 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc. (NBIX) have a share price target of $179.96. This median of share price forecast represents a 27.99% upside from the latest price of $140.6 as on 05.01.26.
As per the chart shown above, analysts believe that the Neurocrine Biosciences Inc. (NBIX) share price will touch around $179.96 in next 12-months.
Below is a chart showing the percentage difference between Neurocrine Biosciences Inc.'s share price and its median forecast price. As on 05.01.26, the difference is -16.16%
Based on 34 analysts tracking and researching Neurocrine Biosciences Inc. (NBIX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 13 | 14 | 14 |
| Outperform | 12 | 12 | 12 |
| Hold | 9 | 9 | 8 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |